Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of dapagliflozin on metabolic control and glycemic pattern in type 1 diabetes
2015-002963-40Phase 2Active
- Sponsor
- Dra Cristina Avendaño Sola
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of dapagliflozin in diabetes mellitus type 1 (T1D), sponsored by Dra Cristina Avendaño Sola. Primary endpoint: Primary HbA1c change at 12 weeks. Started Jul 2015; status: active.
02
Drugs
dapagliflozin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2015-002963-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002963-40.